Work

Study finds GLP‐1 RAs reduced 4‐year mortality by 24% compared to SGLT2 inhibitors in people with SMI

Year: 2026
Type: article
Abstract: The mortality gap for people with bipolar disorder, major depressive disorder, and schizophrenia is mainly due to cardiovascular disease. Individuals with serious mental illness (SMI) have a life expectancy of 10 to 25 years shorter than the general population. This is partly due to psychopharmacotherapy‐related metabolic effects and systemic disparities in prevention and treatment, leading to the need to find interventions that address cardiovascular outcomes and metabolic risk.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7228923161
FWCI:
Cites:
Cited by:
Related to: 10